Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin anti-inflammatory action linked to cardiovascular disease prevention -- NEJM.

This article was originally published in The Tan Sheet

Executive Summary

ASPIRIN ANTI-INFLAMMATORY ACTION LINKED TO CARDIOVASCULAR DISEASE PREVENTION in a study by Paul Ridker, MD, Brigham & Women's Hospital, et al., published in the April 3 New England Journal of Medicine. The analysis involved 1,086 men who participated in the Physicians' Health Study and were randomly assigned regular doses of either 325 mg of aspirin or placebo. The study found that blood levels of C-reactive protein, a marker for systemic inflammation, could predict risk of first myocardial infarction and stroke.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel